SQZ Biotechnologies announced that the appointment of Oliver Rosen as Chief Medical Officer. Dr. Rosen will oversee the clinical development of the company’s cell therapy pipeline and joins the company as it prepares to enter the clinic with a lead oncology candidate. Dr. Rosen has nearly two decades of experience in the healthcare industry, most recently as Chief Medical Officer of Deciphera Pharmaceuticals, where he oversaw the clinical development of the company’s extensive pipeline.